Tilray | TRLY - Loan Capital

Stock Price
9.44
Daily Change
0.45 5.01%
Monthly
-5.32%
Yearly
1,375.00%
Q2 Forecast
8.92

Tilray reported $268.59M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Acasti Pharma USD 0 0 Dec/2024
Akebia Therapeutics USD 48.25M 609K Dec/2025
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Aurora Cannabis CAD 33.2M 1.79M Dec/2025
Avita Medical AUD 42.24M 1.25M Dec/2024
Canopy Growth CAD 224.99M 1.34M Dec/2025
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 20M 0 Mar/2025
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Moderna USD 610M 584M Dec/2025
Organigram Holdings CAD 62.52M 13.88M Dec/2025
Organon & Co USD 8.78B 117M Sep/2025
Revvity USD 2.63B 543K Dec/2025
Tectonic Therapeutic USD 43K 57K Dec/2025
Tilray USD 268.59M 3.82M Sep/2025
Viatris USD 12.48B 7M Dec/2025
Xeris Pharmaceuticals USD 220.33M 866K Dec/2025
Zealand Pharma A/S 383.14M 727K Dec/2025